Item 1. | Security and Issuer. |
This Amendment No. 9 amends the Statement on Schedule 13D filed with the Securities and Exchange Commission on September 29, 1997, as amended by Amendment No. 1 to Schedule 13D filed with the Securities and Exchange Commission on October 10, 1997, by Amendment No. 2 to Schedule 13D filed with the Securities and Exchange Commission on December 23, 1997, by Amendment No. 3 to Schedule 13D filed with the Securities and Exchange Commission on February 2, 1998, by Amendment No. 4 to Schedule 13D filed with the Securities and Exchange Commission on May 18, 2000, by Amendment No. 5 to Schedule 13D filed with the Securities and Exchange Commission on April 7, 2008, by Amendment No. 6 to Schedule 13D filed with the Securities and Exchange Commission on December 16, 2010, by Amendment No. 7 to Schedule 13D filed with the Securit ies and Exchange Commission on January 19, 2011 and by Amendment No. 8 to Schedule 13D filed with the Securities and Exchange Commission on February 7, 2011, by Phoenix Acquisition Company II, L.L.C. (“Phoenix”), Stonington Capital Appreciation 1994 Fund, L.P. (the “Fund”), Stonington Partners, L.P. (“Stonington L.P.”), Stonington Partners, Inc. II (“Stonington II”) and Stonington Partners, Inc. (“Stonington”, and together with Phoenix, the Fund, Stonington L.P. and Stonington II, the “Reporting Persons”). This Amendment No. 9 is filed with respect to the shares of common stock, par value $0.01 per share (the “Common Shares”), of Merisel, Inc., a Delaware corporation (the “Issuer”) with principal executive offices at 127 West 30th Street, 5th Floor, New York, NY 10001.
Item 2. | Identity and Background. |
This Amendment No. 9 amends and substitutes in its entirety Item 2 to state as follows:
This Statement is being filed by and on behalf of the Reporting Persons. Phoenix is a Delaware limited liability company. Each of the Fund and Stonington L.P. is a Delaware limited partnership. Each of Stonington II and Stonington is a Delaware corporation. The principal business of Phoenix is to invest in the capital stock of the Issuer. The principal business of the Fund is investing in securities. The principal business of Stonington L.P. is being the general partner of the Fund. The principal business of Stonington II is being the general partner of Stonington L.P. The principal business of Stonington is being the management company of the Fund.
The directors and officers of Stonington and Stonington II are: Alexis P. Michas, Director and Managing Partner, James J. Burke, Jr., Director and Partner, Bradley J. Hoecker, Director and Partner and John A. Bartholdson, Director and Partner. The principal occupation of each of the directors and officers of Stonington and Stonington II is management of the Fund.
During the last five years, none of the Reporting Persons or the individuals listed in Item 2 has (i) been convicted in a criminal proceeding or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
The business address of each of the Reporting Persons and the individuals listed in this Item 2 is 600 Madison Avenue, 16th Floor, New York, NY 10022.
The citizenship of each of the individuals listed in this Item 2 is of the United States of America.
Item 3. | Source and Amount of Funds or Other Consideration. |
Item 3 is inapplicable to this Amendment No. 9.
Item 4. | Purpose of Transaction. |
This Amendment No. 9 amends and substitutes in its entirety Item 4 to state as follows:
On February 18, 2011, Phoenix and Saints Capital VI, L.P. (“Saints”) executed a stock purchase agreement (the “Agreement”) pursuant to which Phoenix agreed to sell and transfer, and Saints agreed to purchase
and accept, all of the Common Shares and the Issuer’s Series A Preferred Stock (the “Preferred Stock”) held by the Reporting Persons (the “Proposed Transaction”), which together constitute all of the Issuer’s securities owned by the Reporting Persons. The Proposed Transaction is subject to closing conditions, including the completion by Saints of its due diligence review without discovering any new matter which could have a material adverse effect on the Issuer’s business prospects or the value of Saint 217;s investment. If the Proposed Transaction is consummated, it will result in the (i) disposition by the Reporting Persons of their ownership of, and all voting and investment power in respect of, the Common Shares and the Preferred Stock and (ii) acquisition by Saints of ownership of, and all voting and investment power in respect of, the Common Shares and the Preferred Stock.
The foregoing summary of the terms of the Agreement is qualified in its entirety by reference to the full text of the Agreement, a copy of which is included as Exhibit 1 to this Amendment No. 9 and is incorporated herein by reference.
Pursuant to the terms of the Fund’s limited partnership agreement, as amended (the “LP Agreement”), the period for the liquidation or distribution of the portfolio investments of the Fund shall expire on March 31, 2011. Unless such term is extended, any portfolio assets of the Fund, including its investment in the Issuer, must be disposed of or distributed prior to that date, subject to the terms and conditions of the LP agreement. As a result, in the event that the Proposed Transaction is not consummated, the Reporting Persons will consider all available courses of action and may dispose of, or cause to be disposed, any or all of the Common Shares or Preferred Stock held by the Reporting Persons on or before March 31, 2011. Notwithstanding anything contained herein, the Reporting Persons specifically reserve the right to change at any time their intention with respect to any or all of the Common Shares and the Preferred Stock.
The Reporting Persons have no current plan or proposal that relates to, or would result in, any of the actions enumerated in subparagraphs (a) through (j) of Item 4 of Schedule 13D, other than as set forth herein.
Item 5. | Interest in Securities of the Issuer. |
This Amendment No. 9 amends and substitutes in its entirety Item 5 to state as follows:
Phoenix owns beneficially 5,000,000 Common Shares of the Issuer. The number of Common Shares currently held by Phoenix represents 69.3% of the total number of outstanding Common Shares.
Each of: the Fund, as the sole member of Phoenix; Stonington L.P., as the general partner of the Fund; Stonington II, as the general partner of Stonington L.P.; and Stonington, as the management company of the Fund, may be deemed to own beneficially the same number of shares as Phoenix, as described above.
Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer. |
This Amendment No. 9 amends and substitutes in its entirety Item 6 as follows:
The information set forth under Item 4 of this Amendment No. 9 is incorporated by reference into this Item 6.
Item 7. | Material to be Filed as Exhibits. |
The following Exhibits are incorporated herein by reference or filed herewith:
Exhibit 1: Stock Purchase Agreement, dated as of February 18, 2011, by and between Phoenix Acquisition Company II, L.L.C., and Saints Capital VI, L.P.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: February 22, 2011